Published in Immunology on June 01, 1995
Neuropathogenesis of Theiler's murine encephalomyelitis virus infection, an animal model for multiple sclerosis. J Neuroimmune Pharmacol (2009) 1.01
Theiler's viruses with mutations in loop I of VP1 lead to altered tropism and pathogenesis. J Virol (1999) 0.98
Theiler's virus infection induces a predominant pathogenic CD4+ T cell response to RNA polymerase in susceptible SJL/J mice. J Virol (2009) 0.89
Major linear antibody epitopes and capsid proteins differentially induce protective immunity against Theiler's virus-induced demyelinating disease. J Virol (1997) 0.84
Genetic heterogeneity in the leader and P1-coding regions of foot-and-mouth disease virus serotypes A and O in Africa. Arch Virol (2013) 0.77
Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol (1993) 4.23
Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature. J Virol (1994) 2.90
Preparation and characterization of encephalomyocarditis (EMC) virus. Methods Enzymol (1981) 2.81
Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs. J Immunol (1986) 1.76
The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice. J Gen Virol (1987) 1.64
A neutralization-resistant Theiler's virus variant produces an altered disease pattern in the mouse central nervous system. J Virol (1989) 1.59
Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection. J Virol (1991) 1.40
Contrasting effects of immunosuppression on Theiler's virus infection in mice. Infect Immun (1977) 1.33
A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. J Immunol (1991) 1.31
Trypsin-sensitive neutralization site on VP1 of Theiler's murine encephalomyelitis viruses. J Virol (1988) 1.31
Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. II. Survey of host immune responses and central nervous system virus titers in inbred mouse strains. Microb Pathog (1987) 1.24
Cellular immunity in chronic Theiler's virus central nervous system infection. J Immunol (1976) 1.24
Monoclonal anti-I-A antibody reverses chronic paralysis and demyelination in Theiler's virus-infected mice: critical importance of timing of treatment. J Virol (1987) 1.21
Analysis of the human T-cell response to picornaviruses: identification of T-cell epitopes close to B-cell epitopes in poliovirus. J Virol (1993) 1.19
Observations on demyelinating lesions induced by Theiler's virus in CBA mice. Acta Neuropathol (1988) 1.18
Characterization of B lymphocytes present in the demyelinating lesions induced by Theiler's virus. J Immunol (1989) 1.08
Analysis of antibody responses to predominant linear epitopes of Theiler's murine encephalomyelitis virus. J Virol (1994) 1.04
Effect of cyclosporin A, silica quartz dust, and protease inhibitors on virus-induced demyelination. J Neuroimmunol (1986) 1.01
Study of the mechanisms by which CD4+ T cells contribute to protection in Theiler's murine encephalomyelitis. Immunology (1993) 0.96
Identification and localization of a limited number of predominant conformation-independent antibody epitopes of Theiler's murine encephalomyelitus virus. Immunol Lett (1992) 0.94
Characterization and specificity of humoral immune responses to Theiler's murine encephalomyelitis virus capsid proteins. J Gen Virol (1987) 0.90
Neutralizing antibody to Mengo virus, induced by synthetic peptides. J Gen Virol (1991) 0.86
Detection of restricted predominant epitopes of Theiler's murine encephalomyelitis virus capsid proteins expressed in the lambda gt11 system: differential patterns of antibody reactivity among different mouse strains. J Neuroimmunol (1990) 0.86
Lymphocyte recognition of picornaviruses. J Gen Virol (1995) 0.84
Characterization of the immune response to intracerebral inoculation of Theiler's murine encephalomyelitis virus: fine protein specificity of the splenic T cell and humoral antibody response. Immunol Lett (1989) 0.83
Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J Gen Virol (1992) 5.42
Virological and pathological features of mice infected with murine gamma-herpesvirus 68. J Gen Virol (1992) 5.02
Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J Gen Virol (1987) 3.16
Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. J Virol (1993) 2.93
Effect of acycloguanosine treatment of acute and latent herpes simplex infections in mice. Antimicrob Agents Chemother (1979) 2.75
Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68. Am J Pathol (1994) 2.49
Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease. J Virol (1984) 2.48
Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cells. J Gen Virol (1996) 2.37
Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency. J Virol (2000) 2.35
Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice. J Gen Virol (1996) 2.25
Characterization of tumor cell lines derived from murine gammaherpesvirus-68-infected mice. J Virol (1996) 2.19
Cell-mediated immunity in herpes simplex virus-infected mice: induction, characterization and antiviral effects of delayed type hypersensitivity. J Gen Virol (1980) 1.96
Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol (1999) 1.71
Pathogenesis of herpes simplex virus in congenitally athymic mice: the relative roles of cell-mediated and humoral immunity. J Gen Virol (1982) 1.70
Cell-mediated immunity in herpes simplex virus-infected mice: H-2 mapping of the delayed-type hypersensitivity response and the antiviral T cell response. J Immunol (1981) 1.66
Identification and characterization of murine gammaherpesvirus 68 gp150: a virion membrane glycoprotein. J Virol (1996) 1.64
The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice. J Gen Virol (1987) 1.64
Expression of measles virus V protein is associated with pathogenicity and control of viral RNA synthesis. J Virol (1998) 1.63
Pathological changes in the spleens of gamma interferon receptor-deficient mice infected with murine gammaherpesvirus: a role for CD8 T cells. J Virol (1997) 1.54
Interactions of murine gammaherpesvirus 68 with B and T cell lines. Virology (1993) 1.51
Genetic content and preliminary transcriptional analysis of a representative region of murine gammaherpesvirus 68. J Gen Virol (1997) 1.49
Cell-mediated immunity in herpes simplex virus-infected mice: functional analysis of lymph node cells during periods of acute and latent infection, with reference to cytotoxic and memory cells. J Gen Virol (1980) 1.45
Membrane phenotype of murine effector and suppressor T cells involved in delayed hypersensitivity and protective immunity to herpes simplex virus. Cell Immunol (1983) 1.42
Role of antibody in primary and recurrent herpes simplex virus infection. J Virol (1985) 1.41
Tolerance and immunity in mice infected with herpes simplex virus: simultaneous induction of protective immunity and tolerance to delayed-type hypersensitivity. Immunology (1981) 1.36
Characterization of murine gammaherpesvirus 68 glycoprotein B (gB) homolog: similarity to Epstein-Barr virus gB (gp110). J Virol (1994) 1.35
Murine gamma-herpesvirus 68 glycoprotein 150 protects against virus-induced mononucleosis: a model system for gamma-herpesvirus vaccination. Vaccine (1999) 1.34
Type I interferons and IRF-1 play a critical role in the control of a gammaherpesvirus infection. Virology (1999) 1.25
Murine gammaherpesvirus-68 infection causes multi-organ fibrosis and alters leukocyte trafficking in interferon-gamma receptor knockout mice. Am J Pathol (2001) 1.23
Specificity of the immune response of mice to herpes simplex virus glycoproteins B and D constitutively expressed on L cell lines. J Gen Virol (1987) 1.23
Observations on demyelinating lesions induced by Theiler's virus in CBA mice. Acta Neuropathol (1988) 1.18
Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus. J Gen Virol (1991) 1.15
Effect of B cell suppression on primary infection and reinfection of mice with herpes simplex virus. J Infect Dis (1987) 1.14
The role of CD8+T cells in the acute and chronic phases of Theiler's murine encephalomyelitis virus-induced disease in mice. J Gen Virol (1992) 1.13
Analysis of a novel strain of murine gammaherpesvirus reveals a genomic locus important for acute pathogenesis. J Virol (2001) 1.11
Semliki Forest virus strongly reduces mosquito host defence signaling. Insect Mol Biol (2008) 1.09
Split T-cell tolerance in herpes simplex virus-infected mice and its implication for anti-viral immunity. Immunology (1982) 1.08
Cell cycle arrest rather than apoptosis is associated with measles virus contact-mediated immunosuppression in vitro. J Gen Virol (1997) 1.08
Murine gammaherpesvirus M11 gene product inhibits apoptosis and is expressed during virus persistence. Arch Virol (2000) 1.06
The haemagglutinin protein is an important determinant of measles virus tropism for dendritic cells in vitro. J Gen Virol (2001) 1.06
Tolerance and immunity in mice infected with herpes simplex virus: studies on the mechanism of tolerance to delayed-type hypersensitivity. Immunology (1981) 1.04
Pathogenesis of herpes simplex virus in B cell-suppressed mice: the relative roles of cell-mediated and humoral immunity. J Gen Virol (1982) 1.02
Murine gammaherpesvirus-68 infection of and persistence in the central nervous system. J Gen Virol (2000) 1.02
Tolerance and suppression in virus diseases. Br Med Bull (1985) 1.02
A solid-phase system (SPACE) for the detection and quantification of rotavirus in faeces. J Gen Virol (1979) 0.99
Kinetic and phenotypic changes in murine lymphocytes infected with murine gammaherpesvirus-68 in vitro. J Gen Virol (1999) 0.99
Regression of a murine gammaherpesvirus 68-positive b-cell lymphoma mediated by CD4 T lymphocytes. J Virol (2001) 0.98
Immunological control of murine gammaherpesvirus infection is independent of perforin. J Gen Virol (1997) 0.97
Behavioural changes in the rat following infection with varicella-zoster virus. J Gen Virol (1999) 0.96
Study of the mechanisms by which CD4+ T cells contribute to protection in Theiler's murine encephalomyelitis. Immunology (1993) 0.96
Herpes virus latency in sensory ganglia--a comparison with endogenous neuronal gene expression. Prog Neurobiol (2000) 0.96
Characterization of the murine gammaherpesvirus 68 ORF74 product: a novel oncogenic G protein-coupled receptor. J Gen Virol (2001) 0.96
Cell-mediated immunity in herpes simplex virus-infected mice: suppression of delayed hypersensitivity by an antigen-specific B lymphocyte. J Gen Virol (1980) 0.95
Antioxidant status in asthma. Pediatr Pulmonol (1994) 0.95
Lymphocyte subsets and expression of differentiation markers in blood and lymphoid organs of rhesus monkeys. Cytometry (1997) 0.94
Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants. Virology (1990) 0.94
2'-Deoxy-5-ethyl-beta-4'-thiouridine inhibits replication of murine gammaherpesvirus and delays the onset of virus latency. Antivir Chem Chemother (1999) 0.92
Immunological memory to herpes simplex virus type 1 glycoproteins B and D in mice. J Gen Virol (1990) 0.90
Role of neutralizing antibodies and T-cells in pathogenesis of herpes simplex virus infection in congenitally athymic mice. Immunol Lett (1982) 0.89
Clonal analysis of T-cell responses to herpes simplex virus: isolation, characterization and antiviral properties of an antigen-specific helper T-cell clone. Immunology (1984) 0.88
A human leukaemic cell expressing hybrid membrane phenotypes. Nature (1977) 0.87
T cell-macrophage interactions in the immune response to herpes simplex virus: the significance of interferon-gamma. J Gen Virol (1986) 0.87
Expression of glycoprotein D of herpes simplex virus type 1 in a recombinant baculovirus: protective responses and T cell recognition of the recombinant-infected cell extracts. J Gen Virol (1989) 0.86
Expression of the human MxA protein is associated with hyperphosphorylation of VSV P protein in human neural Cells. Virology (1996) 0.86
Lymphocyte recognition of picornaviruses. J Gen Virol (1995) 0.84
Susceptibility to Theiler's virus-induced demyelinating disease correlates with astrocyte class II induction and antigen presentation. Immunology (1992) 0.84
Separation of lymphocyte sub-populations using antibodies attached to staphylococcal protein A-coated surfaces. J Immunol Methods (1976) 0.83
The role of endogenous interleukin-12 in resistance to murine cytomegalovirus (MCMV) infection and a novel action for endogenous IL-12 p40. J Interferon Cytokine Res (1999) 0.82
Delayed-type hypersensitivity response to the human papillomavirus type 16 E7 protein in a mouse model. J Gen Virol (1993) 0.82
Theiler's virus: an experimental model of virus-induced demyelination. Autoimmunity (1990) 0.81
Investigation of the role of delayed-type-hypersensitivity responses to myelin in the pathogenesis of Theiler's virus-induced demyelinating disease. Immunology (1998) 0.80
Effect of MHC transgene expression on spontaneous insulin autoantibody class switch in nonobese diabetic mice. Diabetes (1997) 0.80
CD4(+) T-cells are required for the establishment of maedi-visna virus infection in macrophages but not dendritic cells in vivo. Virology (1999) 0.79
Pathogenesis and immunobiology of herpes simplex virus in mouse and man. Cancer Invest (1985) 0.79
Experimental herpes simplex virus type 1 (HSV-1) infection of the spinal cord and dorsal root ganglia. Neuropathol Appl Neurobiol (1995) 0.78
T cell-macrophage interaction in arginase-mediated resistance to herpes simplex virus. Virus Res (1984) 0.78
Clonal analysis of the T-cell response of mice to herpes simplex virus: correlation between lymphokine production in vitro and the induction of delayed-type hypersensitivity and antiviral activity in vivo. Viral Immunol (1987) 0.78
The PI capsid region of Theiler's virus controls replication in mouse glial cell cultures. Arch Virol (1997) 0.77
The m4 gene of murine gammaherpesvirus modulates productive and latent infection in vivo. J Virol (2004) 0.77
"Natural" presentation of human papillomavirus type-16 E7 protein to immunocompetent mice results in antigen-specific sensitization or sustained unresponsiveness. Eur J Immunol (1994) 0.77
Specific binding sites for prohormone atrial natriuretic peptides 1-30, 31-67 and 99-126. Peptides (1990) 0.77
Expansion and activation of NK cell populations in a gammaherpesvirus infection. Scand J Immunol (2008) 0.76
In vivo depletion of CD8+ cells does not affect primary maedi visna virus infection in sheep. Vet Immunol Immunopathol (1999) 0.76
Characterisation of the immune response in a neural xenograft rejection paradigm. J Neuroimmunol (1997) 0.75
Immune response to murine cell lines of glial origin transplanted into the central nervous system of adult mice. Immunology (1997) 0.75
Clonal analysis of T cell responses to herpes simplex virus: a HSV-specific, non cytolytic T cell clone displays specific helper activity for T cell response in vitro. Immunol Lett (1986) 0.75
Beyond the business plan. J Manag Med (1994) 0.75
Virus-cell interactions in the nervous system and the role of the immune response. Curr Opin Neurobiol (1993) 0.75
Team briefing--helping to rediscover the road to Utopia. Health Manpow Manage (1998) 0.75
Cell-mediated immune responses in herpes simplex virus-infected mice. Prog Brain Res (1983) 0.75
Persistence of anti-immunoglobulin on the lymphocyte surface. Nature (1976) 0.75
Theiler's murine encephalomyelitis virus 3D RNA polymerase: its expression in the CNS and the specific immune response generated in persistently infected mice. J Gen Virol (1995) 0.75
In vitro stimulation of rabbit T lymphocytes by cells expressing herpes simplex antigens. J Gen Virol (1982) 0.75